- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 17:42 | Mineralys presents lorundrostat data in kidney disease patients | ||
| 16:18 | Exelixis presents Cabometyx data for neuroendocrine tumors | ||
| 14:18 | Immunome presents phase 3 trial results for desmoid tumor drug | ||
| 09:30 | Tesla faces a lawsuit in China over Full Self-Driving claims | ||
| 04:54 | Jefferies starts Merck KGaA at Hold, sees limited upside | ||
| 04:54 | Four Corners Property Trust to buy 102 vet properties for $268M | ||
| 02:42 | CLPS receives Nasdaq notice for minimum bid price deficiency | ||
| 02:30 | Cathie Wood's ARK sells Robinhood stock, buys Kratos shares | ||
| 01:42 | New Earth Resources plans C$500,000 private placement | ||
| Fr | Gulf Resources receives second Nasdaq delisting notice | ||
| Fr | Corcept presents survival data for ovarian cancer treatment | ||
| Fr | QXO launches tender offers for TopBuild senior notes | ||
| Fr | Fathom Holdings receives Nasdaq notice for late filing | ||
| Fr | Jade Biosciences to present Phase 1 data for JADE101 on Monday | ||
| Fr | Target Hospitality closes secondary offering of 8.05m shares | ||
| Fr | Sidus Space closes $100 million stock offering | ||
| Fr | Tiptree completes sale of Fortegra to DB Insurance | ||
| Fr | Sinovac faces delisting after missing 2025 annual report filing | ||
| Fr | K92 Mining elects Michael Carew to board of directors | ||
| Fr | TNMP files rate settlement with Texas regulators | ||
| Fr | Oculis phase 3 trials for diabetic macular edema miss endpoint | ||
| Fr | David Taylor of Ohio's 2nd district makes significant trades in Alphabet, Apple, and AT&T | ||
| Fr | Mynd.ai regains NYSE American compliance after filing report | ||
| Fr | NAHL Group posts annual report, sets June 25 AGM date | ||
| Fr | Canal+ shareholders approve all resolutions at annual meeting |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.